Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  HIV Infection

  Free Subscription


27.02.2017

5 AIDS
4 HIV Med
1 Immunology
7 J Acquir Immune Defic Syndr
1 Lancet
1 Lancet Haematol
4 Lancet HIV
1 Lancet Respir Med
1 PLoS Med
13 PLoS One
3 PLoS Pathog
1 Proc Natl Acad Sci U S A
1 Science


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    AIDS

  1. TOMESCU C, Tebas P, Montaner LJ
    IFN-alpha augments natural killer-mediated antibody-dependent cellular cytotoxicity of HIV-1-infected autologous CD4+ T cells regardless of major histocompatibility complex class 1 downregulation.
    AIDS. 2017;31:613-622.
    PubMed     Text format     Abstract available

  2. LINNEMAYR S, Stecher C, Mukasa B
    Behavioral economic incentives to improve adherence to antiretroviral medication.
    AIDS. 2017;31:719-726.
    PubMed     Text format     Abstract available

  3. KONG X, Kigozi G, Ssekasanvu J, Nalugoda F, et al
    Medical male circumcision coverage in Rakai, Uganda.
    AIDS. 2017;31:735-737.
    PubMed     Text format     Abstract available

  4. CZAICKI NL, Holmes CB, Sikazwe I, Bolton C, et al
    Nonadherence to antiretroviral therapy among HIV-infected patients in Zambia is concentrated among a minority of patients and is highly variable across clinics.
    AIDS. 2017;31:689-696.
    PubMed     Text format     Abstract available

  5. HARAWA NT, Holloway IW, Leibowitz A, Weiss R, et al
    Serious concerns regarding a meta-analysis of preexposure prophylaxis use and STI acquisition.
    AIDS. 2017;31:739-740.
    PubMed     Text format    


    HIV Med

  6. MENA A, Meijide H, Rodriguez-Osorio I, Castro A, et al
    Liver-related mortality and hospitalizations attributable to chronic hepatitis C virus coinfection in persons living with HIV.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12502.
    PubMed     Text format     Abstract available

  7. PUHR R, Petoumenos K, Youds D, Law MG, et al
    The impact of changes in HIV management guidelines on time to treatment initiation in Australia.
    HIV Med. 2017 Feb 22. doi: 10.1111/hiv.12504.
    PubMed     Text format    

  8. RALLON N, Restrepo C, Vicario JL, Del Romero J, et al
    Human leucocyte antigen (HLA)-DQB1*03:02 and HLA-A*02:01 have opposite patterns in their effects on susceptibility to HIV infection.
    HIV Med. 2017 Feb 20. doi: 10.1111/hiv.12494.
    PubMed     Text format     Abstract available

  9. WANG Z, Wu X, Lau J, Mo P, et al
    Prevalence of and factors associated with unprotected anal intercourse with regular and nonregular male sexual partners among newly diagnosed HIV-positive men who have sex with men in China.
    HIV Med. 2017 Feb 23. doi: 10.1111/hiv.12500.
    PubMed     Text format     Abstract available


    Immunology

  10. RUFFIN N, Hani L, Seddiki N
    From Dendritic cells to B cells dysfunctions during HIV-1 infection: Tfh at the cross road.
    Immunology. 2017 Feb 23. doi: 10.1111/imm.12730.
    PubMed     Text format     Abstract available


    J Acquir Immune Defic Syndr

  11. HOENIGL M, Braun DL, Kouyos R, Gunthard HF, et al
    Evaluation of the Predictive Potential of the Short Acute Retroviral Syndrome Severity Score for HIV-1 Disease Progression in Individuals With Acute HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:e114-e117.
    PubMed     Text format    

  12. HELMUT A, Dillingham R, Hogg RS, Jaworsky D, et al
    The Continuum of HIV Care in Rural Communities in the United States and Canada: What Is Known and Future Research Directions.
    J Acquir Immune Defic Syndr. 2017 Feb 16. doi: 10.1097/QAI.0000000000001329.
    PubMed     Text format     Abstract available

  13. HAALAND RE, Holder A, Pau CP, Swaims-Kohlmeier A, et al
    Levels of intracellular phosphorylated tenofovir and emtricitabine correlate with natural substrate concentrations in peripheral blood mononuclear cells of persons prescribed daily oral TruvadaTM for HIV pre-exposure prophylaxis.
    J Acquir Immune Defic Syndr. 2017 Feb 14. doi: 10.1097/QAI.0000000000001324.
    PubMed     Text format    

  14. PASTOR L, Parker E, Carrillo J, Urrea V, et al
    A Cytokine Pattern That Differentiates Preseroconversion From Postseroconversion Phases of Primary HIV Infection.
    J Acquir Immune Defic Syndr. 2017;74:459-466.
    PubMed     Text format     Abstract available

  15. CLOUSE K, Vermund SH, Maskew M, Lurie MN, et al
    Mobility and Clinic Switching Among Postpartum Women Considered Lost to HIV Care in South Africa.
    J Acquir Immune Defic Syndr. 2017;74:383-389.
    PubMed     Text format     Abstract available

  16. MARGOLICK JB, Bream JH, Martinez-Maza O, Lopez J, et al
    Frailty and Circulating Markers of Inflammation in HIV+ and HIV- Men in the Multicenter AIDS Cohort Study.
    J Acquir Immune Defic Syndr. 2017;74:407-417.
    PubMed     Text format     Abstract available

  17. AGSALDA-GARCIA MA, Sithinamsuwan P, Valcour VG, Chalermchai T, et al
    Brief Report: CD14+ Enriched Peripheral Cells Secrete Cytokines Unique to HIV-Associated Neurocognitive Disorders.
    J Acquir Immune Defic Syndr. 2017;74:454-458.
    PubMed     Text format     Abstract available


    Lancet

  18. DOWNS JA, Mwakisole AH, Chandika AB, Lugoba S, et al
    Educating religious leaders to promote uptake of male circumcision in Tanzania: a cluster randomised trial.
    Lancet. 2017 Feb 14. pii: S0140-6736(16)32055.
    PubMed     Text format     Abstract available


    Lancet Haematol

  19. FERRERI AJ, Sassone M, Zaja F, Re A, et al
    Lenalidomide maintenance in patients with relapsed diffuse large B-cell lymphoma who are not eligible for autologous stem cell transplantation: an open label, single-arm, multicentre phase 2 trial.
    Lancet Haematol. 2017 Feb 16. pii: S2352-3026(17)30016.
    PubMed     Text format     Abstract available


    Lancet HIV

  20. SAX PE, DeJesus E, Crofoot G, Ward D, et al
    Bictegravir versus dolutegravir, each with emtricitabine and tenofovir alafenamide, for initial treatment of HIV-1 infection: a randomised, double-blind, phase 2 trial.
    Lancet HIV. 2017 Feb 14. pii: S2352-3018(17)30016.
    PubMed     Text format     Abstract available

  21. BARBER T
    Integrase inhibitors go head-to-head.
    Lancet HIV. 2017 Feb 14. pii: S2352-3018(17)30017.
    PubMed     Text format    

  22. FRYE V, Koblin BA
    HIV self-testing in high-risk populations.
    Lancet HIV. 2017 Feb 16. pii: S2352-3018(17)30024.
    PubMed     Text format    

  23. JAMIL MS, Prestage G, Fairley CK, Grulich AE, et al
    Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial.
    Lancet HIV. 2017 Feb 16. pii: S2352-3018(17)30023.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  24. ANDREWS JR, Nemes E, Tameris M, Landry BS, et al
    Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study.
    Lancet Respir Med. 2017 Feb 16. pii: S2213-2600(17)30060.
    PubMed     Text format     Abstract available


    PLoS Med

  25. MIKKELSEN E, Hontelez JA, Jansen MP, Barnighausen T, et al
    Evidence for scaling up HIV treatment in sub-Saharan Africa: A call for incorporating health system constraints.
    PLoS Med. 2017;14:e1002240.
    PubMed     Text format     Abstract available


    PLoS One

  26. ABRAM ME, Ram RR, Margot NA, Barnes TL, et al
    Lack of impact of pre-existing T97A HIV-1 integrase mutation on integrase strand transfer inhibitor resistance and treatment outcome.
    PLoS One. 2017;12:e0172206.
    PubMed     Text format     Abstract available

  27. WU PY, Cheng CY, Liu CE, Lee YC, et al
    Multicenter study of skin rashes and hepatotoxicity in antiretroviral-naive HIV-positive patients receiving non-nucleoside reverse-transcriptase inhibitor plus nucleoside reverse-transcriptase inhibitors in Taiwan.
    PLoS One. 2017;12:e0171596.
    PubMed     Text format     Abstract available

  28. ARNOLD T, Brinkley-Rubinstein L, Chan PA, Perez-Brumer A, et al
    Social, structural, behavioral and clinical factors influencing retention in Pre-Exposure Prophylaxis (PrEP) care in Mississippi.
    PLoS One. 2017;12:e0172354.
    PubMed     Text format     Abstract available

  29. TEIXEIRA LB, Pilecco FB, Vigo A, Drachler ML, et al
    Factors associated with post-diagnosis pregnancies in women living with HIV in the south of Brazil.
    PLoS One. 2017;12:e0172514.
    PubMed     Text format     Abstract available

  30. JAWORSKI JP, Bryk P, Brower Z, Zheng B, et al
    Pre-existing neutralizing antibody mitigates B cell dysregulation and enhances the Env-specific antibody response in SHIV-infected rhesus macaques.
    PLoS One. 2017;12:e0172524.
    PubMed     Text format     Abstract available

  31. NGOLE-JEME VM, Fantke P
    Ecological and human health risks associated with abandoned gold mine tailings contaminated soil.
    PLoS One. 2017;12:e0172517.
    PubMed     Text format     Abstract available

  32. SAFARNEJAD A, Izazola-Licea JA
    Direct and indirect effects of enablers on HIV testing, initiation and retention in antiretroviral treatment and AIDS related mortality.
    PLoS One. 2017;12:e0172569.
    PubMed     Text format     Abstract available

  33. DEB A, Johnson WA, Kline AP, Scott BJ, et al
    Bacterial expression, correct membrane targeting and functional folding of the HIV-1 membrane protein Vpu using a periplasmic signal peptide.
    PLoS One. 2017;12:e0172529.
    PubMed     Text format     Abstract available

  34. WONG WC, Zhao Y, Wong NS, Parish WL, et al
    Prevalence and risk factors of chlamydia infection in Hong Kong: A population-based geospatial household survey and testing.
    PLoS One. 2017;12:e0172561.
    PubMed     Text format     Abstract available

  35. ELMES J, Skovdal M, Nhongo K, Ward H, et al
    A reconfiguration of the sex trade: How social and structural changes in eastern Zimbabwe left women involved in sex work and transactional sex more vulnerable.
    PLoS One. 2017;12:e0171916.
    PubMed     Text format     Abstract available

  36. KANMOGNE GD, Qiu F, Ntone FE, Fonsah JY, et al
    Depressive symptoms in HIV-infected and seronegative control subjects in Cameroon: Effect of age, education and gender.
    PLoS One. 2017;12:e0171956.
    PubMed     Text format     Abstract available

  37. MIDDE NM, Sinha N, Lukka PB, Meibohm B, et al
    Alterations in cellular pharmacokinetics and pharmacodynamics of elvitegravir in response to ethanol exposure in HIV-1 infected monocytic (U1) cells.
    PLoS One. 2017;12:e0172628.
    PubMed     Text format     Abstract available

  38. SCHLUSSER KE, Pilcher C, Kallas EG, Santos BR, et al
    Comparison of cross-sectional HIV incidence assay results from dried blood spots and plasma.
    PLoS One. 2017;12:e0172283.
    PubMed     Text format     Abstract available


    PLoS Pathog

  39. IRIMIA A, Serra AM, Sarkar A, Jacak R, et al
    Lipid interactions and angle of approach to the HIV-1 viral membrane of broadly neutralizing antibody 10E8: Insights for vaccine and therapeutic design.
    PLoS Pathog. 2017;13:e1006212.
    PubMed     Text format     Abstract available

  40. BUI JK, Halvas EK, Fyne E, Sobolewski MD, et al
    Ex vivo activation of CD4+ T-cells from donors on suppressive ART can lead to sustained production of infectious HIV-1 from a subset of infected cells.
    PLoS Pathog. 2017;13:e1006230.
    PubMed     Text format     Abstract available

  41. TANWAR HS, Khoo KK, Garvey M, Waddington L, et al
    The thermodynamics of Pr55Gag-RNA interaction regulate the assembly of HIV.
    PLoS Pathog. 2017;13:e1006221.
    PubMed     Text format     Abstract available


    Proc Natl Acad Sci U S A

  42. BALDAUF HM, Stegmann L, Schwarz SM, Ambiel I, et al
    Vpx overcomes a SAMHD1-independent block to HIV reverse transcription that is specific to resting CD4 T cells.
    Proc Natl Acad Sci U S A. 2017 Feb 22. pii: 201613635.
    PubMed     Text format     Abstract available


    Science

  43. PUJANANDEZ L
    Peak HIV viremia pushes CD8+ T cells.
    Science. 2017;355:706-707.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: